JPH04297461A - 2-thiohydantoin derivative - Google Patents
2-thiohydantoin derivativeInfo
- Publication number
- JPH04297461A JPH04297461A JP6279491A JP6279491A JPH04297461A JP H04297461 A JPH04297461 A JP H04297461A JP 6279491 A JP6279491 A JP 6279491A JP 6279491 A JP6279491 A JP 6279491A JP H04297461 A JPH04297461 A JP H04297461A
- Authority
- JP
- Japan
- Prior art keywords
- group
- lower alkyl
- formula
- phenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical class O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 title claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 14
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 12
- 239000012442 inert solvent Substances 0.000 abstract description 5
- 239000002253 acid Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 230000003356 anti-rheumatic effect Effects 0.000 abstract description 2
- 230000000840 anti-viral effect Effects 0.000 abstract description 2
- 150000002540 isothiocyanates Chemical class 0.000 abstract description 2
- CJGZGANQCWTRCM-UHFFFAOYSA-N 5-(benzylsulfanylmethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-2-sulfanylideneimidazolidin-4-one Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(N2C(C(CSCC=3C=CC=CC=3)NC2=S)=O)=C1 CJGZGANQCWTRCM-UHFFFAOYSA-N 0.000 abstract 1
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- -1 α-phenethyl Chemical group 0.000 description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- LJSMGWBQOFWAPJ-UHFFFAOYSA-N 4-methoxy-3-(naphthalen-1-ylmethyl)-4-oxobutanoic acid Chemical compound C1=CC=C2C(CC(CC(O)=O)C(=O)OC)=CC=CC2=C1 LJSMGWBQOFWAPJ-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- GHBAYRBVXCRIHT-VIFPVBQESA-N S-benzyl-L-cysteine zwitterion Chemical compound OC(=O)[C@@H](N)CSCC1=CC=CC=C1 GHBAYRBVXCRIHT-VIFPVBQESA-N 0.000 description 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000006351 ethylthiomethyl group Chemical group [H]C([H])([H])C([H])([H])SC([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PKHMTIRCAFTBDS-UHFFFAOYSA-N hexanoyl hexanoate Chemical compound CCCCCC(=O)OC(=O)CCCCC PKHMTIRCAFTBDS-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、新規な2−チオヒダン
トイン誘導体に関する。FIELD OF THE INVENTION This invention relates to novel 2-thiohydantoin derivatives.
【0002】0002
【従来の技術】本発明化合物は、文献未載の新規化合物
である。BACKGROUND OF THE INVENTION The compound of the present invention is a novel compound that has not been described in any literature.
【0003】0003
【発明が解決しようとする課題】本発明は、後記するよ
うに医薬品として有用な化合物を提供することを目的と
する。OBJECTS OF THE INVENTION The object of the present invention is to provide compounds useful as pharmaceuticals, as described below.
【0004】0004
【課題を解決するための手段】本発明によれば、下記一
般式(1)で表される2−チオヒダントイン誘導体が提
供される。According to the present invention, a 2-thiohydantoin derivative represented by the following general formula (1) is provided.
【0005】[0005]
【化2】
[式中R1 は低級アルキル基、低級アルケニル基、フ
ェニル低級アルキル基又は置換基として低級アルキル基
、低級アルコキシ基、ハロゲン原子、低級アルコキシカ
ルボニル基及び水酸基から選ばれる基を1〜3個有する
フェニル基を、R2 は水素原子又は低級アルカノイル
基を、R3 は水素原子、低級アルキル基、フェニル基
、フェニル低級アルキル基又は低級アルコキシ基を有す
ることのあるフェニル基の1〜3個で置換されていても
よい低級アルキルチオ低級アルキル基をそれぞれ示す。
但し、R1 がメチル基、R2 が水素原子で且つR3
がメチルチオメチル基であるものを除く。][Formula R1 is a lower alkyl group, a lower alkenyl group, a phenyl lower alkyl group, or a group selected from a lower alkyl group, a lower alkoxy group, a halogen atom, a lower alkoxycarbonyl group, and a hydroxyl group as a substituent from 1 to 3] R2 is a hydrogen atom or a lower alkanoyl group, and R3 is a hydrogen atom, a lower alkyl group, a phenyl group, a phenyl lower alkyl group, or a phenyl group that may have a lower alkoxy group. Lower alkylthio lower alkyl group which may be substituted. However, R1 is a methyl group, R2 is a hydrogen atom, and R3
Excludes those in which is a methylthiomethyl group. ]
【0006】上記一般式(1)で表される本発明の2−
チオヒダントイン誘導体は、抗菌、抗ウイルス、抗炎症
、抗リウマチ等の各種薬理作用を示し、抗菌剤、抗ウイ
ルス剤、抗炎症剤、抗リウマチ剤等の医薬品として有用
である。2- of the present invention represented by the above general formula (1)
Thiohydantoin derivatives exhibit various pharmacological actions such as antibacterial, antiviral, antiinflammatory, and antirheumatic, and are useful as pharmaceuticals such as antibacterial agents, antiviral agents, antiinflammatory agents, and antirheumatic agents.
【0007】本発明化合物を示す上記一般式(1)及び
その他の本明細書において、低級アルキル基としては、
例えばメチル、エチル、プロピル、イソプロピル、ブチ
ル、イソブチル、tert−ブチル、ペンチル、ヘキシ
ル基等の直鎖又は分岐鎖状低級アルキル基を例示できる
。低級アルケニル基としては、例えばビニル、アリル、
2−ブテニル、3−ブテニル、1−メチル−2−プロペ
ニル、2−ペンテニル、3−メチル−2−ブテニル、2
−ヘキセニル基等を例示できる。フェニル低級アルキル
基としては、例えばベンジル、α−フェネチル、β−フ
ェネチル、3−フェニルプロピル、4−フェニルブチル
、1,1−ジメチル−2−フェニルエチル、5−フェニ
ルペンチル、6−フェニルヘキシル基等を例示できる。
低級アルコキシ基としては、例えばメトキシ、エトキシ
、プロポキシ、ブトキシ、tert−ブトキシ、ペンチ
ルオキシ、ヘキシルオキシ基等を例示できる。低級アル
コキシカルボニル基としては、例えばメトキシカルボニ
ル、エトキシカルボニル、プロポキシカルボニル、ブト
キシカルボニル、tert−ブトキシカルボニル、ペン
チルオキシカルボニル、ヘキシルオキシ基等を例示でき
る。ハロゲン原子には弗素原子、塩素原子、臭素原子及
び沃素原子が包含される。低級アルカノイル基としては
、例えばアセチル、プロピオニル、ブチリル、イソブチ
リル、バレリル、イソバレリル、トリメチルアセチル、
ヘキサノイル基等を例示できる。置換基として低級アル
キル基、低級アルコキシ基、ハロゲン原子、低級アルコ
キシカルボニル基及び水酸基から選ばれる基を1〜3個
有するフェニル基としては、例えば4−メチルフェニル
、3−メチルフェニル、4−エチルフェニル、4−メト
キシフェニル、3−メトキシフェニル、3,4−ジメト
キシフェニル、4−クロロフェニル、3−クロロフェニ
ル、4−ブロモフェニル、4−メトキシカルボニルフェ
ニル、4−エトキシカルボニルフェニル、4−ヒドロキ
シフェニル、4−ヒドロキシ−3,5−ジ−tert−
ブチルフェニル基等を例示できる。低級アルコキシ基を
有することのあるフェニル基の1〜3個で置換されてい
てもよい低級アルキルチオ低級アルキル基としては、例
えばメチルチオメチル、ベンジルチオメチル、4−メト
キシベンジルチオメチル、トリフェニルメチルチオメチ
ル、2−ベンジルチオエチル、1−ベンジルチオエチル
、エチルチオメチル、エチルチオエチル、α−フェネチ
ルチオメチル、β−フェネチルチオメチル、3−ベンジ
ルチオプロピル、3−(3−フェニルプロピルチオ)プ
ロピル基等を例示できる。[0007] In the above general formula (1) showing the compound of the present invention and others in this specification, the lower alkyl group is:
Examples include linear or branched lower alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, and hexyl groups. Examples of lower alkenyl groups include vinyl, allyl,
2-butenyl, 3-butenyl, 1-methyl-2-propenyl, 2-pentenyl, 3-methyl-2-butenyl, 2
-hexenyl group, etc. can be exemplified. Examples of phenyl lower alkyl groups include benzyl, α-phenethyl, β-phenethyl, 3-phenylpropyl, 4-phenylbutyl, 1,1-dimethyl-2-phenylethyl, 5-phenylpentyl, 6-phenylhexyl, and the like. can be exemplified. Examples of lower alkoxy groups include methoxy, ethoxy, propoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy groups. Examples of lower alkoxycarbonyl groups include methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, tert-butoxycarbonyl, pentyloxycarbonyl, and hexyloxy groups. Halogen atoms include fluorine atoms, chlorine atoms, bromine atoms and iodine atoms. Examples of lower alkanoyl groups include acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, trimethylacetyl,
Examples include hexanoyl groups. Examples of the phenyl group having 1 to 3 groups selected from a lower alkyl group, a lower alkoxy group, a halogen atom, a lower alkoxycarbonyl group, and a hydroxyl group as substituents include 4-methylphenyl, 3-methylphenyl, and 4-ethylphenyl. , 4-methoxyphenyl, 3-methoxyphenyl, 3,4-dimethoxyphenyl, 4-chlorophenyl, 3-chlorophenyl, 4-bromophenyl, 4-methoxycarbonylphenyl, 4-ethoxycarbonylphenyl, 4-hydroxyphenyl, 4- Hydroxy-3,5-di-tert-
Examples include butylphenyl group. Examples of the lower alkylthio lower alkyl group optionally substituted with 1 to 3 phenyl groups that may have a lower alkoxy group include methylthiomethyl, benzylthiomethyl, 4-methoxybenzylthiomethyl, triphenylmethylthiomethyl, 2-benzylthioethyl, 1-benzylthioethyl, ethylthiomethyl, ethylthioethyl, α-phenethylthiomethyl, β-phenethylthiomethyl, 3-benzylthiopropyl, 3-(3-phenylpropylthio)propyl group, etc. I can give an example.
【0008】本発明の2−チオヒダントイン誘導体は、
各種の方法により製造することができる。その具体例を
下記反応工程式に示す。
<反応工程式−1>The 2-thiohydantoin derivative of the present invention is
It can be manufactured by various methods. A specific example thereof is shown in the reaction scheme below. <Reaction scheme-1>
【0009】[0009]
【化3】 [式中R1 及びR3 はそれぞれ前記に同じ。][Chemical formula 3] [In the formula, R1 and R3 are each the same as above. ]
【0
010】上記反応工程式−1に示すイソチオシアネート
誘導体(2)と化合物(3)との反応は、以下の要領で
実施できる。即ち、化合物(2)と化合物(3)とを適
当な不活性溶媒中で加熱した後、酸で処理する。上記に
おいて不活性溶媒としては、例えばN,N−ジメチルホ
ルムアミド(DMF)、エタノール等を使用できる。加
熱条件としては、一般に室温〜100℃の温度範囲にて
約1〜5時間程度を採用できる。得られる粗生成物は、
引き続いて酢酸、ポリリン酸等の酸と共に室温〜100
℃で約10〜60分間処理を行なうことにより、目的化
合物(1a)に導くことができる。
〈反応工程式−2〉0
The reaction between the isothiocyanate derivative (2) shown in the above reaction scheme-1 and the compound (3) can be carried out in the following manner. That is, compound (2) and compound (3) are heated in a suitable inert solvent and then treated with an acid. In the above, as the inert solvent, for example, N,N-dimethylformamide (DMF), ethanol, etc. can be used. As the heating conditions, it is generally possible to adopt a temperature range of room temperature to 100° C. for about 1 to 5 hours. The crude product obtained is
Subsequently, with an acid such as acetic acid or polyphosphoric acid, the
The target compound (1a) can be obtained by treatment at a temperature of about 10 to 60 minutes. <Reaction scheme-2>
【0011】[0011]
【化4】
[式中R1 及びR3 は前記に同じ。R2aは低級ア
ルカノイル基を示す。]embedded image [In the formula, R1 and R3 are the same as above. R2a represents a lower alkanoyl group. ]
【0012】上記反応工程式−2において、化合物(1
a)のアルカノイル化反応は、塩基性溶媒中で又は塩基
触媒の存在下に不活性溶媒中で、原料化合物と酸無水物
とを反応させることにより行ない得る。上記塩基性溶媒
としては、例えばピリジン、コリジン、ルチジン、トリ
エチルアミン等を使用できる。不活性溶媒としては、例
えばTHF、ジエチルエーテル、クロロホルム、ジクロ
ロメタン、DMF等を使用でき、この場合上記塩基性溶
媒を塩基触媒として約1〜3倍モル量程度併用する。ま
た、酸無水物としては、例えば無水酢酸、無水プロピオ
ン酸、無水酪酸、無水吉草酸、無水カプロン酸、無水ヘ
プタン酸等を使用できる。反応は、0〜100℃の温度
条件下に、1〜24時間程度で完結し、かくして目的化
合物(1b)が得られる。In the above reaction scheme-2, compound (1
The alkanoylation reaction a) can be carried out by reacting the starting compound and the acid anhydride in a basic solvent or in an inert solvent in the presence of a basic catalyst. As the basic solvent, for example, pyridine, collidine, lutidine, triethylamine, etc. can be used. As the inert solvent, for example, THF, diethyl ether, chloroform, dichloromethane, DMF, etc. can be used, and in this case, the above-mentioned basic solvent is used in combination as a base catalyst in about 1 to 3 times the molar amount. Further, as the acid anhydride, for example, acetic anhydride, propionic anhydride, butyric anhydride, valeric anhydride, caproic anhydride, heptanoic anhydride, etc. can be used. The reaction is completed in about 1 to 24 hours under a temperature condition of 0 to 100°C, and thus the target compound (1b) is obtained.
【0013】上記それぞれの工程における目的化合物は
、通常の分離手段により容易に単離精製することができ
る。この分離手段としては、慣用される各種方法、例え
ば、溶媒抽出法、再結晶、吸着クロマトグラフィー、イ
オン交換クロマトグラフィー等を例示できる。The target compounds in each of the above steps can be easily isolated and purified by conventional separation means. Examples of this separation means include various commonly used methods, such as solvent extraction, recrystallization, adsorption chromatography, and ion exchange chromatography.
【0014】[0014]
【実施例】以下、本発明を更に詳しく説明するため、本
発明化合物の製造例を実施例として挙げる。EXAMPLES In order to explain the present invention in more detail, examples of the production of the compounds of the present invention will be given below as examples.
【0015】[0015]
【実施例1】3−(3,5−ジ−tert−ブチル−4
−ヒドロキシフェニル)−5−ベンジルチオメチル−2
−チオヒダントインの製造
4−フェニル−3,5−ジ−tert−ブチルフェニル
イソチオシアネート5gとS−ベンジルシステイン4.
1gをDMF300mlに溶解し、80℃で1.8時間
撹拌した。反応液中に水を入れ、酢酸エチルで抽出し、
酢酸エチル層を無水炭酸マグネシウムで乾燥後、濃縮し
て油状物質を得た。次に、この油状物質を100mlの
酢酸に溶かし、95〜100℃で45分撹拌した。酢酸
を減圧留去し、残渣に飽和炭酸水素ナトリウム水溶液を
加え、クロロホルムで抽出した。クロロホルム層を無水
炭酸マグネシウムで乾燥後、濃縮して得られた粗生成物
をシリカゲルカラムクロマトグラフィー(展開溶媒…ク
ロロホルム:酢酸エチル=30:1)にて精製し、目的
化合物7.7gを得た。得られた化合物の構造並びに物
性を、化合物1として第1表に示す。[Example 1] 3-(3,5-di-tert-butyl-4
-hydroxyphenyl)-5-benzylthiomethyl-2
-Preparation of thiohydantoin 5 g of 4-phenyl-3,5-di-tert-butylphenyl isothiocyanate and S-benzyl cysteine 4.
1 g was dissolved in 300 ml of DMF and stirred at 80° C. for 1.8 hours. Add water to the reaction solution, extract with ethyl acetate,
The ethyl acetate layer was dried over anhydrous magnesium carbonate and concentrated to obtain an oily substance. This oil was then dissolved in 100 ml of acetic acid and stirred at 95-100°C for 45 minutes. Acetic acid was distilled off under reduced pressure, and a saturated aqueous sodium bicarbonate solution was added to the residue, followed by extraction with chloroform. After drying the chloroform layer over anhydrous magnesium carbonate, the resulting crude product was purified by silica gel column chromatography (developing solvent: chloroform: ethyl acetate = 30:1) to obtain 7.7 g of the target compound. . The structure and physical properties of the obtained compound are shown in Table 1 as Compound 1.
【0016】[0016]
【実施例2〜13】実施例1と同様にして、第1表に示
す各化合物(化合物2〜13)を製造した。得られた各
化合物の構造及び物性を第1表に併記する。Examples 2 to 13 The compounds shown in Table 1 (compounds 2 to 13) were produced in the same manner as in Example 1. The structure and physical properties of each compound obtained are also listed in Table 1.
【0017】[0017]
【実施例14】1−アセチル−3−メチル−5−ベンジ
ルチオメチル−2−チオヒダントインの製造実施例8で
得られた化合物(化合物8)300mgにピリジン3m
lと無水酢酸0.3mlを加え、室温にて1夜撹拌した
。反応混合物を氷水中に入れ、酢酸エチルで抽出した。
酢酸エチル層を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後濃縮した。得られた粗生成物をシリカゲル
カラムクロマトグラフィー(展開溶媒…ジエチルエーテ
ル:n−ヘキサン=1:3)にて精製し、目的化合物3
17mgを得た。得られた化合物の構造並びに物性を第
1表に示す。[Example 14] Production of 1-acetyl-3-methyl-5-benzylthiomethyl-2-thiohydantoin To 300 mg of the compound obtained in Example 8 (compound 8) was added 3 m of pyridine.
1 and 0.3 ml of acetic anhydride were added, and the mixture was stirred at room temperature overnight. The reaction mixture was placed in ice water and extracted with ethyl acetate. The ethyl acetate layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated. The obtained crude product was purified by silica gel column chromatography (developing solvent: diethyl ether: n-hexane = 1:3) to obtain the target compound 3.
17 mg was obtained. The structure and physical properties of the obtained compound are shown in Table 1.
【0018】[0018]
【実施例15】実施例14と同様にして、第1表に示す
化合物(化合物15)を製造した。得られた化合物の構
造及び物性を第1表に併記する。Example 15 The compound shown in Table 1 (Compound 15) was produced in the same manner as in Example 14. The structure and physical properties of the obtained compound are also listed in Table 1.
【0019】[0019]
【実施例16〜21】実施例1と同様にして、第1表に
示す各化合物(化合物16〜21)を製造した。得られ
た各化合物の構造及び物性を第1表に併記する。Examples 16 to 21 In the same manner as in Example 1, the compounds shown in Table 1 (Compounds 16 to 21) were produced. The structure and physical properties of each compound obtained are also listed in Table 1.
【0020】[0020]
【表1】[Table 1]
【0021】[0021]
【表2】[Table 2]
【0022】[0022]
【表3】[Table 3]
【0023】[0023]
【表4】[Table 4]
【0024】[0024]
【表5】[Table 5]
【0025】[0025]
【表6】[Table 6]
Claims (1)
ェニル低級アルキル基又は置換基として低級アルキル基
、低級アルコキシ基、ハロゲン原子、低級アルコキシカ
ルボニル基及び水酸基から選ばれる基を1〜3個有する
フェニル基を、R2 は水素原子又は低級アルカノイル
基を、R3 は水素原子、低級アルキル基、フェニル基
、フェニル低級アルキル基又は低級アルコキシ基を有す
ることのあるフェニル基の1〜3個で置換されていても
よい低級アルキルチオ低級アルキル基をそれぞれ示す。 但し、R1 がメチル基でR2 が水素原子で且つR3
がメチルチオメチル基であるものを除く。]で表され
る2−チオヒダントイン誘導体。Claim 1: General formula [Formula 1] [In the formula, R1 is a lower alkyl group, a lower alkenyl group, a phenyl lower alkyl group, or a lower alkyl group, a lower alkoxy group, a halogen atom, a lower alkoxycarbonyl group, or a hydroxyl group as a substituent] A phenyl group having 1 to 3 selected groups, R2 is a hydrogen atom or a lower alkanoyl group, and R3 is a phenyl group that may have a hydrogen atom, a lower alkyl group, a phenyl group, a phenyl lower alkyl group, or a lower alkoxy group. represents a lower alkylthio lower alkyl group which may be substituted with 1 to 3 of the following. However, R1 is a methyl group, R2 is a hydrogen atom, and R3
Excludes those in which is a methylthiomethyl group. ] A 2-thiohydantoin derivative represented by.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6279491A JPH04297461A (en) | 1991-03-27 | 1991-03-27 | 2-thiohydantoin derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6279491A JPH04297461A (en) | 1991-03-27 | 1991-03-27 | 2-thiohydantoin derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04297461A true JPH04297461A (en) | 1992-10-21 |
Family
ID=13210613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6279491A Pending JPH04297461A (en) | 1991-03-27 | 1991-03-27 | 2-thiohydantoin derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04297461A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
US5599829A (en) * | 1995-11-28 | 1997-02-04 | American Home Products Corporation | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels |
US5663363A (en) * | 1996-11-21 | 1997-09-02 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5783707A (en) * | 1995-11-28 | 1998-07-21 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
WO1998033777A1 (en) * | 1997-01-31 | 1998-08-06 | Shionogi & Co., Ltd. | Compounds having metalloprotease inhibitory activity |
US5821372A (en) * | 1995-11-28 | 1998-10-13 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5861517A (en) * | 1996-11-21 | 1999-01-19 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5877324A (en) * | 1995-11-28 | 1999-03-02 | American Home Products Corporation | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50142564A (en) * | 1970-10-06 | 1975-11-17 | ||
JPS52100470A (en) * | 1976-02-20 | 1977-08-23 | Yoshitomi Pharmaceut Ind Ltd | Synthesis of hydantoin derivatives |
JPS52100469A (en) * | 1976-02-20 | 1977-08-23 | Yoshitomi Pharmaceut Ind Ltd | Hydantoin derivatives |
JPS5492962A (en) * | 1977-12-01 | 1979-07-23 | Wellcome Found | Thiohydantoin compound |
JPS5551068A (en) * | 1978-10-09 | 1980-04-14 | Kyowa Hakko Kogyo Co Ltd | Novel hydantoin derivative, and antiphlogistic analgesic agent containing the same |
JPS55133362A (en) * | 1979-02-20 | 1980-10-17 | Inst Nat Radio Elements | Diphenylhydantoin derivative*medical drug containing it and its manufacture |
JPH02101066A (en) * | 1988-08-11 | 1990-04-12 | Bayer Ag | N-aryl nitrogen heterocyclic compound |
-
1991
- 1991-03-27 JP JP6279491A patent/JPH04297461A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50142564A (en) * | 1970-10-06 | 1975-11-17 | ||
JPS52100470A (en) * | 1976-02-20 | 1977-08-23 | Yoshitomi Pharmaceut Ind Ltd | Synthesis of hydantoin derivatives |
JPS52100469A (en) * | 1976-02-20 | 1977-08-23 | Yoshitomi Pharmaceut Ind Ltd | Hydantoin derivatives |
JPS5492962A (en) * | 1977-12-01 | 1979-07-23 | Wellcome Found | Thiohydantoin compound |
JPS5551068A (en) * | 1978-10-09 | 1980-04-14 | Kyowa Hakko Kogyo Co Ltd | Novel hydantoin derivative, and antiphlogistic analgesic agent containing the same |
JPS55133362A (en) * | 1979-02-20 | 1980-10-17 | Inst Nat Radio Elements | Diphenylhydantoin derivative*medical drug containing it and its manufacture |
JPH02101066A (en) * | 1988-08-11 | 1990-04-12 | Bayer Ag | N-aryl nitrogen heterocyclic compound |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
US5599829A (en) * | 1995-11-28 | 1997-02-04 | American Home Products Corporation | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels |
US5783707A (en) * | 1995-11-28 | 1998-07-21 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5821372A (en) * | 1995-11-28 | 1998-10-13 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5877324A (en) * | 1995-11-28 | 1999-03-02 | American Home Products Corporation | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives |
US5663363A (en) * | 1996-11-21 | 1997-09-02 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
US5861517A (en) * | 1996-11-21 | 1999-01-19 | American Home Products Corporation | 2-thioxo-imidazolidin-4-one derivatives |
WO1998033777A1 (en) * | 1997-01-31 | 1998-08-06 | Shionogi & Co., Ltd. | Compounds having metalloprotease inhibitory activity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU199497B (en) | Process for producing acid addition salts, alcohol solvates and hydrates of 7-halogen-7-deoxylincomycin | |
JPH01211567A (en) | Novel sulfonamide compound | |
JP3030780B2 (en) | Optically active ketene dithioacetal derivative and method for producing the same | |
JPH04297461A (en) | 2-thiohydantoin derivative | |
EP0002978B1 (en) | Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications | |
HU191824B (en) | Process for producing new pyridine and pyrimidine derivatives utilizable as intermediares producing antiflogistic and immunkregulating compounds | |
JPH0774194B2 (en) | A novel actinonine derivative with physiological activity | |
FR2460934A1 (en) | ISOQUINOLINE DERIVATIVES CONTAINING SULFUR, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
US5102900A (en) | Imidazoles useful as antiatherosclerotic agents | |
JPS6355512B2 (en) | ||
PT87187B (en) | PROCESS FOR THE SYNTHESIS OF ALPHA- (1-METHYL-ETHYL) -3,4-DIMETOXY-BENZENE-ACETONITRYL | |
SU895283A3 (en) | Method of preparing alpha-alkyl-0-oxybenzylamine derivatives or their salts | |
FR2660313A1 (en) | NEW SULFONYL-PHENYL-BETHA-D-THIOXYLOSIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPEUTICS | |
CA1321593C (en) | 2-sulphinyl-acetyl-1,3-thiazolidines, their preparation and pharmaceutical compositions | |
JP2631668B2 (en) | New urocanic acid derivatives | |
US5004833A (en) | KS-501 derivatives | |
JPS61112056A (en) | Imidazole derivative and production thereof | |
WO1993015082A1 (en) | SEPARATION OF ISOMERS OF FURO[3,4-c]PYRIDINE DERIVATIVES | |
JPS6388168A (en) | 3-benzoylpropionic acid derivative | |
JPS6140669B2 (en) | ||
US4160096A (en) | Process for production of 5-nitroimidazole derivatives | |
JPS6032783A (en) | Fluorine-containing coumarins | |
JPS6287599A (en) | Production of oxime derivative of erythromycin | |
HU193853B (en) | Process for preparing dioxolo-benzisoxazole derivatives | |
JPH02233670A (en) | Piperazinosulfonic acid derivative |